Polyrizon Ltd. PLRZ 深 沪
等待开盘 03-27 09:30:00 美东时间
13.75
-0.480
-3.37%
华盛通- 最 高15.50
- 今 开14.15
- 成交量 7141股
- 最 低 11.7865
- 昨 收 14.23
- 总市值 0
- 52周最高 18.20
- 市盈率 静 --
- 换手率 Infinity.00%
- 52周最低 0.0032
- 委 比 -52.11%
- 总股本 --
- 历史最高 18.20
- 量 比 0.33
- 振 幅 26.10%
- 历史最低 0.0032
- 每 手 1
- 风险率
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Polyrizon Starts Key Usability Study Program For Its NASARIX Product Candidate
Polyrizon Ltd. (NASDAQ:PLRZ) ("Polyrizon" or the "Company"), a pre-clinical-stage biotechnology company developing intranasal protective solutions, today announced the initiation of a key usability (Human Factors) study
01-22 22:29
Polyrizon Completes Branding Of PL-14 Allergy Blocker As NASARIX, Advancing Commercial Readiness
As part of the branding process, Polyrizon conducted comprehensive trademark screening across the U.S. and European marketsRaanana, Israel, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Polyrizon Ltd. Polyrizon Ltd.
01-08 21:47
Why GH Research Shares Are Trading Higher By 18%; Here Are 20 Stocks Moving Premarket
Shares of GH Research PLC (NASDAQ:GHRS) rose sharply in pre-market trading afte...
01-05 17:27
Polyrizon Explores Revenue-Generating Asset Investments While Advancing Core Biotech Pipeline
Polyrizon Ltd. Polyrizon Ltd. (NASDAQ:PLRZ) ("Polyrizon" or the "Company"), a pre-clinical-stage biotechnology company developing intranasal protective solutions, today announced that its Board of Directors has decided
2025-12-29 20:21
What Sparked Polyrizon's (PLRZ) 140% After-Hours Stock Surge?
Polyrizon surged in nearly 140% after-hours trading following preclinical data showing its naloxone hydrogel outperforms a marketed spray and a key manufacturing milestone.
2025-12-04 10:52
Gold Down Over 1%; Signet Shares Fall After Q3 Results
U.S. stocks traded higher midway through trading, with the Dow Jones gaining ar...
2025-12-03 01:29
Nasdaq Surges 200 Points; United Natural Foods Posts Upbeat Earnings
U.S. stocks traded higher this morning, with the Nasdaq Composite gaining aroun...
2025-12-02 22:50
Polyrizon Completes Manufacturing Upscaling Milestone For Its Proprietary Nasal-Spray Product Platform
Polyrizon Ltd. (NASDAQ:PLRZ) ("Polyrizon" or the "Company"), a biotechnology company developing intranasal products based on its proprietary Capture & Contain (C&C) platform, today announced the successful
2025-12-02 20:57
Polyrizon Announces Positive In-Vitro Results For Its PL-16 Viral Blocker Candidate Against H1N1 Influenza
Polyrizon Ltd. (NASDAQ:PLRZ) ("Polyrizon" or the "Company"), a biotechnology company developing intranasal products based on its proprietary Capture & Contain (C&C) platform, today announced positive in-vitro
2025-11-06 21:58
